DAVID R BETHUNE Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID R BETHUNE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID R BETHUNE. DAVID R BETHUNE is CEO/Chairman in ATRIX LABORATORIES INC ($ATRX) and Chief Executive Officer in ATRIX LABORATORIES INC ($ATRX) and Director in FEMALE HEALTH CO ($FHCO).
Latest Insider Trading Transactions of DAVID R BETHUNE
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 01 2018 | VERU | VERU INC. | BETHUNE DAVID R | Director | Option Exercise | M | 0.00 | 140,000 | 0 | 0 | |
| Nov 01 2018 | VERU | VERU INC. | BETHUNE DAVID R | Director | Buy | M | 0.00 | 140,000 | 0 | 575,982 | 436 K to 576 K (+32.11 %) |
| May 04 2018 | VERU | VERU INC. | BETHUNE DAVID R | Director | Option Exercise | A | 1.89 | 50,000 | 94,500 | 50,000 | |
| Aug 04 2017 | FHCO | VERU INC. | BETHUNE DAVID R | Director | Option Exercise | A | 1.20 | 50,000 | 60,000 | 50,000 | |
| May 17 2017 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Buy | P | 1.03 | 10,000 | 10,305 | 435,982 | 426 K to 436 K (+2.35 %) |
| May 15 2017 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Buy | P | 1.03 | 10,000 | 10,299 | 425,982 | 416 K to 426 K (+2.40 %) |
| May 15 2017 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Buy | P | 1.03 | 10,000 | 10,278 | 415,982 | 406 K to 416 K (+2.46 %) |
| Dec 15 2016 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Buy | P | 1.06 | 200 | 212 | 405,982 | 405.8 K to 406 K (+0.05 %) |
| Nov 02 2016 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Option Exercise | A | 0.95 | 140,000 | 133,000 | 420,000 | |
| Nov 02 2016 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Option Exercise | A | 0.00 | 140,000 | 0 | 280,000 | |
| Nov 02 2016 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Option Exercise | A | 0.95 | 140,000 | 133,000 | 140,000 | |
| Nov 02 2016 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Option Exercise | M | 0.00 | 16,667 | 0 | 0 | |
| Nov 02 2016 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Buy | M | 0.00 | 16,667 | 0 | 405,782 | 389.1 K to 405.8 K (+4.28 %) |
| Nov 02 2016 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Grant | A | 0.00 | 140,000 | 0 | 389,115 | 249.1 K to 389.1 K (+56.20 %) |
| Sep 09 2016 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Option Exercise | M | 0.00 | 8,333 | 0 | 0 | |
| Sep 09 2016 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Sell | D | 1.32 | 8,333 | 11,000 | 249,115 | 257.4 K to 249.1 K (-3.24 %) |
| Sep 09 2016 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Buy | M | 0.00 | 8,333 | 0 | 257,448 | 249.1 K to 257.4 K (+3.35 %) |
| May 23 2016 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Buy | P | 1.26 | 100 | 126 | 249,115 | 249 K to 249.1 K (+0.04 %) |
| Aug 28 2015 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Aug 28 2015 | FHCO | FEMALE HEALTH CO | BETHUNE DAVID R | Director | Grant | A | 0.00 | 50,000 | 0 | 249,015 | 199 K to 249 K (+25.12 %) |
| Oct 06 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Option Exercise | M | 9.75 | 10,000 | 97,500 | 70,000 | |
| Oct 06 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Sell | S | 32.02 | 10,000 | 320,190 | 146,477 | 156.5 K to 146.5 K (-6.39 %) |
| Oct 06 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Buy | M | 9.75 | 10,000 | 97,500 | 156,477 | 146.5 K to 156.5 K (+6.83 %) |
| Sep 08 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Option Exercise | M | 9.75 | 10,000 | 97,500 | 80,000 | |
| Sep 08 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Sell | S | 29.21 | 10,000 | 292,100 | 146,477 | 156.5 K to 146.5 K (-6.39 %) |
| Sep 08 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Buy | M | 9.75 | 10,000 | 97,500 | 156,477 | 146.5 K to 156.5 K (+6.83 %) |
| Aug 05 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Option Exercise | M | 9.75 | 10,000 | 97,500 | 90,000 | |
| Aug 05 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Sell | S | 30.57 | 10,000 | 305,700 | 146,477 | 156.5 K to 146.5 K (-6.39 %) |
| Aug 05 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Buy | M | 9.75 | 10,000 | 97,500 | 156,477 | 146.5 K to 156.5 K (+6.83 %) |
| Jul 06 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Option Exercise | M | 9.72 | 10,000 | 97,190 | 0 | |
| Jul 06 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Sell | S | 33.04 | 10,000 | 330,400 | 146,477 | 156.5 K to 146.5 K (-6.39 %) |
| Jul 06 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Buy | M | 9.72 | 10,000 | 97,190 | 156,477 | 146.5 K to 156.5 K (+6.83 %) |
| Jun 08 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Option Exercise | M | 9.72 | 4,000 | 38,876 | 10,000 | |
| Jun 08 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Option Exercise | M | 9.94 | 4,000 | 39,752 | 0 | |
| Jun 08 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Option Exercise | M | 9.63 | 2,000 | 19,250 | 0 | |
| Jun 08 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Sell | S | 28.50 | 10,000 | 284,950 | 146,477 | 156.5 K to 146.5 K (-6.39 %) |
| Jun 08 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Buy | M | 9.72 | 4,000 | 38,876 | 156,477 | 152.5 K to 156.5 K (+2.62 %) |
| Jun 08 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Buy | M | 9.94 | 4,000 | 39,752 | 152,477 | 148.5 K to 152.5 K (+2.69 %) |
| Jun 08 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Buy | M | 9.63 | 2,000 | 19,250 | 148,477 | 146.5 K to 148.5 K (+1.37 %) |
| Jun 08 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Option Exercise | M | 9.72 | 4,000 | 38,876 | 10,000 | |
| Jun 08 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Option Exercise | M | 9.94 | 4,000 | 39,752 | 0 | |
| Jun 08 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Option Exercise | M | 9.63 | 2,000 | 19,250 | 0 | |
| Jun 08 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Sell | S | 28.50 | 10,000 | 284,950 | 146,477 | 156.5 K to 146.5 K (-6.39 %) |
| Jun 08 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Buy | M | 9.72 | 4,000 | 38,876 | 156,477 | 152.5 K to 156.5 K (+2.62 %) |
| Jun 08 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Buy | M | 9.94 | 4,000 | 39,752 | 152,477 | 148.5 K to 152.5 K (+2.69 %) |
| Jun 08 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | CEO/Chairman | Buy | M | 9.63 | 2,000 | 19,250 | 148,477 | 146.5 K to 148.5 K (+1.37 %) |
| May 10 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | Chief Executive Off ... | Option Exercise | A | 31.00 | 50,000 | 1,550,000 | 50,000 | |
| May 10 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | Chief Executive Off ... | Option Exercise | M | 9.63 | 8,000 | 77,000 | 2,000 | |
| May 10 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | Chief Executive Off ... | Option Exercise | M | 6.88 | 2,000 | 13,760 | 0 | |
| May 10 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | Chief Executive Off ... | Sell | S | 31.16 | 10,000 | 311,620 | 146,477 | 156.5 K to 146.5 K (-6.39 %) |
| May 10 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | Chief Executive Off ... | Buy | M | 9.63 | 8,000 | 77,000 | 156,477 | 148.5 K to 156.5 K (+5.39 %) |
| May 10 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | Chief Executive Off ... | Buy | M | 6.88 | 2,000 | 13,760 | 148,477 | 146.5 K to 148.5 K (+1.37 %) |
| May 10 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | Chief Executive Off ... | Option Exercise | A | 31.00 | 50,000 | 1,550,000 | 50,000 | |
| May 10 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | Chief Executive Off ... | Option Exercise | M | 9.63 | 8,000 | 77,000 | 2,000 | |
| May 10 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | Chief Executive Off ... | Option Exercise | M | 6.88 | 2,000 | 13,760 | 0 | |
| May 10 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | Chief Executive Off ... | Sell | S | 31.16 | 10,000 | 311,620 | 146,477 | 156.5 K to 146.5 K (-6.39 %) |
| May 10 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | Chief Executive Off ... | Buy | M | 9.63 | 8,000 | 77,000 | 156,477 | 148.5 K to 156.5 K (+5.39 %) |
| May 10 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | Chief Executive Off ... | Buy | M | 6.88 | 2,000 | 13,760 | 148,477 | 146.5 K to 148.5 K (+1.37 %) |
| Dec 04 2003 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | Chief Executive Off ... | Option Exercise | M | 9.72 | 26,000 | 252,694 | 14,000 | |
| Dec 04 2003 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | Chief Executive Off ... | Buy | M | 9.72 | 26,000 | 252,694 | 146,477 | 120.5 K to 146.5 K (+21.58 %) |
Page: 1